NSC 617145

CAS No. 203115-63-3

NSC 617145( NSC617145 )

Catalog No. M13160 CAS No. 203115-63-3

NSC 617145 is a novel small-molecule, selective inhibitor of WRN helicase with IC50 of 230 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 73 Get Quote
2MG 42 Get Quote
5MG 67 Get Quote
10MG 92 Get Quote
25MG 167 Get Quote
50MG 235 Get Quote
100MG 369 Get Quote
200MG Get Quote Get Quote
500MG 870 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    NSC 617145
  • Note
    Research use only, not for human use.
  • Brief Description
    NSC 617145 is a novel small-molecule, selective inhibitor of WRN helicase with IC50 of 230 nM.
  • Description
    NSC 617145 is a novel small-molecule, selective inhibitor of WRN helicase with IC50 of 230 nM; shows no significant inhibition on BLM, FANCJ, ChlR1, RecQ, and UvrD; acts synergistically with very low concentrations of mitomycin C to inhibit proliferation in a WRN-dependent manner and induce DSB and chromosomal abnormalities in FA-D2(-/-) cells.
  • In Vitro
    NSC 617145 (0.75-3 μM; 24-72 hours) shows maximal inhibition of proliferation (98%) at the lowest concentration in a WRN-specific manner in HeLa cells.NSC 617145 (0.75 μM; 6 hours) induces WRN binding to chromatin and proteasomal degradation.In FA-D2-/- cells, NSC 617145 (0.125 μM) acts synergistically with very low concentrations of Mitomycin C to inhibit proliferation in a WRN-dependent manner and induce double-strand breaks (DSB) and chromosomal abnormalities. NSC 617145 exposure results in enhanced accumulation of DNA-PKcs pS2056 foci and Rad51 foci in Mitomycin C-treated FA-deficient cells, suggesting that WRN helicase inhibition prevents processing of Rad51-mediated recombination products and activates NHEJ.NSC 617145, induces cell cycle arrest and apoptosis in human T-cell leukemia virus type 1 (HTLV-1)-transformed adult T-cell leukemia cells. Cell Viability Assay Cell Line:HeLa cells.Concentration:0.75 μM, 1 μM, 1.5 μM, 2 μM, 3 μM Incubation Time:24 hours, 48 hours, 72 hours Result:Inhibited cell proliferation in a WRN-specific manner.Western Blot Analysis Cell Line:HeLa cells Concentration:0.75 μM Incubation Time:6 hours Result:Caused WRN to become degraded by a proteasome-mediated pathway.
  • In Vivo
    ——
  • Synonyms
    NSC617145
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    DNA Repair Protein
  • Recptor
    DNA Repair Protein
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    203115-63-3
  • Formula Weight
    400.04
  • Molecular Formula
    C13H10Cl4N2O4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 10 mg/mL (25.00 mM)
  • SMILES
    CC(C)(CN1C(=O)C(=C(C1=O)Cl)Cl)CN2C(=O)C(=C(C2=O)Cl)Cl
  • Chemical Name
    1,1'-(2,2-Dimethyl-1,3-propanediyl)bis[3,4-dichloro-1H-pyrrole-2,5-dione

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Aggarwal M, et al. Cancer Res. 2013 Sep 1;73(17):5497-507. 2. Aggarwal M, et al. Cell Cycle. 2013 Oct 15;12(20):3329-35. 3. Moles R, et al. J Hematol Oncol. 2016 Nov 9;9(1):121.
molnova catalog
related products
  • HUHS-015

    HUHS-015 (HUHS015)?is a potent, orally active prostate cancer antigen-1 (PCA-1/ALKBH3) inhibitor with IC50 of 0.67 uM.

  • IACS-4619

    IACS-4759 potent, selective aminopyrimidine MTH1 (MutT homolog 1) inhibitor with IC50 of 0.2 nM.

  • PFM01

    PFM01 (SML1735) is a small molecule that specifically inhibits endonuclease, but not exonuclease activity of MRE11, inhibits dsDNA end resection in A549 cells with IC50 of 50-75 uM, blocks the ssDNA-binding path toward the catalytic metal ions and disrupts endonuclease activity.